These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 30818081)

  • 1. Conserved functions of RNA-binding proteins in muscle.
    Nikonova E; Kao SY; Ravichandran K; Wittner A; Spletter ML
    Int J Biochem Cell Biol; 2019 May; 110():29-49. PubMed ID: 30818081
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antagonistic regulation of mRNA expression and splicing by CELF and MBNL proteins.
    Wang ET; Ward AJ; Cherone JM; Giudice J; Wang TT; Treacy DJ; Lambert NJ; Freese P; Saxena T; Cooper TA; Burge CB
    Genome Res; 2015 Jun; 25(6):858-71. PubMed ID: 25883322
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of MBNL and CELF mRNA transcripts in muscles with myotonic dystrophy.
    Nezu Y; Kino Y; Sasagawa N; Nishino I; Ishiura S
    Neuromuscul Disord; 2007 Apr; 17(4):306-12. PubMed ID: 17331722
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Muscleblind family of proteins: an emerging class of regulators of developmentally programmed alternative splicing.
    Pascual M; Vicente M; Monferrer L; Artero R
    Differentiation; 2006 Mar; 74(2-3):65-80. PubMed ID: 16533306
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Muscleblind proteins regulate alternative splicing.
    Ho TH; Charlet-B N; Poulos MG; Singh G; Swanson MS; Cooper TA
    EMBO J; 2004 Aug; 23(15):3103-12. PubMed ID: 15257297
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An engineered RNA binding protein with improved splicing regulation.
    Hale MA; Richardson JI; Day RC; McConnell OL; Arboleda J; Wang ET; Berglund JA
    Nucleic Acids Res; 2018 Apr; 46(6):3152-3168. PubMed ID: 29309648
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ABLIM1 splicing is abnormal in skeletal muscle of patients with DM1 and regulated by MBNL, CELF and PTBP1.
    Ohsawa N; Koebis M; Mitsuhashi H; Nishino I; Ishiura S
    Genes Cells; 2015 Feb; 20(2):121-34. PubMed ID: 25403273
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MBNL expression in autoregulatory feedback loops.
    Konieczny P; Stepniak-Konieczna E; Sobczak K
    RNA Biol; 2018 Jan; 15(1):1-8. PubMed ID: 28949831
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Conserved functional antagonism of CELF and MBNL proteins controls stem cell-specific alternative splicing in planarians.
    Solana J; Irimia M; Ayoub S; Orejuela MR; Zywitza V; Jens M; Tapial J; Ray D; Morris Q; Hughes TR; Blencowe BJ; Rajewsky N
    Elife; 2016 Aug; 5():. PubMed ID: 27502555
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Muscle-specific expression of the RNA-binding protein Staufen1 induces progressive skeletal muscle atrophy via regulation of phosphatase tensin homolog.
    Crawford Parks TE; Ravel-Chapuis A; Bondy-Chorney E; Renaud JM; Côté J; Jasmin BJ
    Hum Mol Genet; 2017 May; 26(10):1821-1838. PubMed ID: 28369467
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ancient antagonism between CELF and RBFOX families tunes mRNA splicing outcomes.
    Gazzara MR; Mallory MJ; Roytenberg R; Lindberg JP; Jha A; Lynch KW; Barash Y
    Genome Res; 2017 Aug; 27(8):1360-1370. PubMed ID: 28512194
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The CELF family of RNA binding proteins is implicated in cell-specific and developmentally regulated alternative splicing.
    Ladd AN; Charlet N; Cooper TA
    Mol Cell Biol; 2001 Feb; 21(4):1285-96. PubMed ID: 11158314
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sense and Antisense DMPK RNA Foci Accumulate in DM1 Tissues during Development.
    Michel L; Huguet-Lachon A; Gourdon G
    PLoS One; 2015; 10(9):e0137620. PubMed ID: 26339785
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Developmental regulation of RNA processing by Rbfox proteins.
    Conboy JG
    Wiley Interdiscip Rev RNA; 2017 Mar; 8(2):. PubMed ID: 27748060
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Candidate RNAi Screen Reveals Diverse RNA-Binding Protein Phenotypes in
    Kao SY; Nikonova E; Chaabane S; Sabani A; Martitz A; Wittner A; Heemken J; Straub T; Spletter ML
    Cells; 2021 Sep; 10(10):. PubMed ID: 34685485
    [TBL] [Abstract][Full Text] [Related]  

  • 16. miR-30-5p Regulates Muscle Differentiation and Alternative Splicing of Muscle-Related Genes by Targeting MBNL.
    Zhang BW; Cai HF; Wei XF; Sun JJ; Lan XY; Lei CZ; Lin FP; Qi XL; Plath M; Chen H
    Int J Mol Sci; 2016 Jan; 17(2):. PubMed ID: 26840300
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Muscleblind isoforms are functionally distinct and regulate alpha-actinin splicing.
    Vicente M; Monferrer L; Poulos MG; Houseley J; Monckton DG; O'dell KM; Swanson MS; Artero RD
    Differentiation; 2007 Jun; 75(5):427-40. PubMed ID: 17309604
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alternative splicing regulation by Muscleblind proteins: from development to disease.
    Fernandez-Costa JM; Llamusi MB; Garcia-Lopez A; Artero R
    Biol Rev Camb Philos Soc; 2011 Nov; 86(4):947-58. PubMed ID: 21489124
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanistic determinants of MBNL activity.
    Sznajder ŁJ; Michalak M; Taylor K; Cywoniuk P; Kabza M; Wojtkowiak-Szlachcic A; Matłoka M; Konieczny P; Sobczak K
    Nucleic Acids Res; 2016 Dec; 44(21):10326-10342. PubMed ID: 27733504
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mis-splicing of Tau exon 10 in myotonic dystrophy type 1 is reproduced by overexpression of CELF2 but not by MBNL1 silencing.
    Dhaenens CM; Tran H; Frandemiche ML; Carpentier C; Schraen-Maschke S; Sistiaga A; Goicoechea M; Eddarkaoui S; Van Brussels E; Obriot H; Labudeck A; Gevaert MH; Fernandez-Gomez F; Charlet-Berguerand N; Deramecourt V; Maurage CA; Buée L; Lopez de Munain A; Sablonnière B; Caillet-Boudin ML; Sergeant N
    Biochim Biophys Acta; 2011 Jul; 1812(7):732-42. PubMed ID: 21439371
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.